Vascular angiotensin-converting enzyme expression regulates local angiotensin II.

We tested the hypothesis that changes in angiotensin-converting enzyme (ACE) gene expression can regulate the rate of local vascular angiotensin II (Ang II) production. We perfused isolated rat hindlimbs with an artificial medium and infused renin and Ang I via the perfusate. Ang I and II were measured by radioimmunoassay. We then increased ACE gene expression and ACE levels in the rat aorta by producing two-kidney, one clip (2K1C) hypertension for 4 weeks. Gene expression was measured by RNAse protection assay, and ACE activity in the vessel wall was measured by the Cushman-Cheung assay. Angiotensin I infusion at 1, 10, 100, and 1000 pmol/mL led to 371 +/- 14 (+/-SEM), 3611 +/- 202, 44,828 +/- 1425, and 431,503 +/- 16,439 fmol/mL Ang II released, respectively, from the hindlimbs (r = .98, P < .001). Thus, the conversion rate did not change across four orders of magnitude, and the system was not saturable under these conditions. In 2K1C hindlimbs, Ang I infusion (0.5 pmol/mL) resulted in increased Ang II generation (157 +/- 16 versus 123 +/- 23 fmol/mL, P = .014 at minute 10) compared with controls. ACE gene expression and ACE activity were increased in 2K1C hindlimbs compared with controls (36 +/- 4 versus 17 +/- 1 mU/mg protein, P < .001). Ang II degradation in the two groups did not differ. To investigate the conversion of locally generated Ang I, we infused porcine renin (0.5 milliunits per mL) into 2K1C and control hindlimbs. Despite markedly higher Ang I release in sham-operated than in 2K1C rats (71 +/- 8 versus 37 +/- 6 pmol/mL, P = .008 at minute 12), Ang II was only moderately increased (36 +/- 3 versus 25 +/- 6 pmol/mL, P = .12 at minute 12). This difference between 2K1C rats and controls reflected a higher rate of conversion in 2K1C rats. Thus, Ang I conversion in the rat hindlimb is linear over a wide range of substrate concentrations and occurs at a fixed relationship. Nevertheless, increased ACE gene expression and ACE activity in the vessel wall lead to an increase in the conversion of Ang I to Ang II. We conclude that local ACE gene expression and ACE activity can influence the local rate of Ang II production.

[1]  H. Schunkert,et al.  Angiotensin-converting enzyme in the human heart. Effect of the deletion/insertion polymorphism. , 1995, Circulation.

[2]  J. Connell,et al.  Polymorphisms in angiotensin-converting-enzyme gene and progression of IgA nephropathy , 1995, The Lancet.

[3]  D. Ganten,et al.  Chronic dexamethasone treatment suppresses hypertension development in the transgenic rat TGR(mREN2)27 , 1995, Journal of hypertension.

[4]  E. Vicaut,et al.  ACE in three tunicae of rat aorta: expression in smooth muscle and effect of renovascular hypertension. , 1994, The American journal of physiology.

[5]  Hiroaki Tanaka,et al.  Angiotensin II formation by an alternative pathway during exercise in humans , 1994, Journal of hypertension.

[6]  L. Ng,et al.  Activity and density of the Na+/H+ antiporter in normal and transformed human lymphocytes and fibroblasts. , 1994, The American journal of physiology.

[7]  D. Ganten,et al.  Differential regulation of vascular angiotensin I-converting enzyme in hypertension. , 1994, Hypertension.

[8]  H. Schunkert,et al.  Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. , 1994, The New England journal of medicine.

[9]  J. Krieger,et al.  Induction of angiotensin converting enzyme in the neointima after vascular injury. Possible role in restenosis. , 1994, The Journal of clinical investigation.

[10]  A. Marian,et al.  Angiotensin-converting enzyme polymorphism in hypertrophic cardiomyopathy and sudden cardiac death , 1993, The Lancet.

[11]  D. Ganten,et al.  Vascular conversion of angiotensin I in stroke-prone spontaneously hypertensive and Wistar—Kyoto rats , 1993, Journal of hypertension.

[12]  M. Miyazaki,et al.  Marked species-difference in the vascular angiotensin II-forming pathways: humans versus rodents. , 1993, Japanese journal of pharmacology.

[13]  T. Ogihara,et al.  Novel and effective gene transfer technique for study of vascular renin angiotensin system. , 1993, The Journal of clinical investigation.

[14]  H. Inui,et al.  Regulation of vascular angiotensin release. , 1993, Hypertension.

[15]  O. Costerousse,et al.  Angiotensin I-converting enzyme in human circulating mononuclear cells: genetic polymorphism of expression in T-lymphocytes. , 1993, The Biochemical journal.

[16]  H. Pieterman,et al.  Regional angiotensin II production in essential hypertension and renal artery stenosis. , 1993, Hypertension.

[17]  C. Johnston.  Franz Volhard Lecture. Renin-angiotensin system: a dual tissue and hormonal system for cardiovascular control. , 1992, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[18]  Philippe Amouyel,et al.  Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction , 1992, Nature.

[19]  M. Schalekamp.  The rennin???angiotensin system: new surprises ahead , 1991 .

[20]  G. M. Lathrop,et al.  Chromosomal mapping of two genetic loci associated with blood-pressure regulation in hereditary hypertensive rats , 1991, Nature.

[21]  D. Ganten,et al.  Local angiotensin formation in hindlimbs of uremic hypertensive and renovascular hypertensive rats , 1991, Journal of hypertension.

[22]  P. Corvol,et al.  Distribution of plasma angiotensin I-converting enzyme levels in healthy men: relationship to environmental and hormonal parameters. , 1991, The Journal of laboratory and clinical medicine.

[23]  F. Cambien,et al.  Similar Frequencies of Renin Gene Restriction Fragment Length Polymorphisms in Hypertensive and Normotensive Subjects , 1990, Hypertension.

[24]  H. Schunkert,et al.  Increased rat cardiac angiotensin converting enzyme activity and mRNA expression in pressure overload left ventricular hypertrophy. Effects on coronary resistance, contractility, and relaxation. , 1990, The Journal of clinical investigation.

[25]  E. G. Erdös,et al.  Angiotensin I converting enzyme and the changes in our concepts through the years. Lewis K. Dahl memorial lecture. , 1990, Hypertension.

[26]  P Corvol,et al.  An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. , 1990, The Journal of clinical investigation.

[27]  D. Campbell,et al.  METABOLISM OF TETRADECAPEPTIDE, ANGIOTENSINOGEN AND ANGIOTENSIN I AND II BY ISOLATED PERFUSED RAT HINDLIMBS , 1990, Clinical and experimental pharmacology & physiology.

[28]  B. Healy,et al.  Angiotensin II-forming pathways in normal and failing human hearts. , 1990, Circulation research.

[29]  H. Pieterman,et al.  Metabolism and Production of Angiotensin I in Different Vascular Beds in Subjects With Hypertension , 1990, Hypertension.

[30]  D. Ganten,et al.  Angiotensin formation in the isolated rat hindlimb. , 1989, Journal of hypertension.

[31]  J. Wood,et al.  Biochemical effects of prolonged renin inhibition in marmosets. , 1989, Journal of hypertension.

[32]  D. Campbell,et al.  Circulating and tissue angiotensin systems. , 1987, The Journal of clinical investigation.

[33]  M. Miyazaki,et al.  Vascular renin-angiotensin system in two-kidney, one clip hypertensive rats. , 1986, Hypertension.

[34]  J. Ménard,et al.  Effects of antihypertensive treatment in one-clip, two kidney hypertension in rats. , 1986, Kidney international.

[35]  L. Resnick,et al.  Angiotensin I converting enzyme activity in hypertension. Relationship to blood pressure, renin-sodium profiles, and antihypertensive therapy. , 1985, The American journal of medicine.

[36]  D. Campbell.  The site of angiotensin production. , 1985, Journal of hypertension.

[37]  C. N. Gillis,et al.  Apparent kinetics of angiotensin converting enzyme: hydrolysis of [3H]benzoyl-phenylalanyl-alanyl-proline in the isolated perfused lung. , 1985, The Journal of pharmacology and experimental therapeutics.

[38]  M. Miyazaki,et al.  Evidence for a putatively new angiotensin II-generating enzyme in the vascular wall. , 1984, Journal of hypertension.

[39]  C. Auffray,et al.  Purification of mouse immunoglobulin heavy-chain messenger RNAs from total myeloma tumor RNA. , 2005, European journal of biochemistry.

[40]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[41]  B. Seegal,et al.  Angiotensin-converting enzyme: vascular endothelial localization. , 1976, Science.

[42]  S. Britton,et al.  Effects of angiotensin I and angiotensin II on hindlimb and coronary vascular resistance. , 1973, The American journal of physiology.

[43]  J. Vane,et al.  Inhibition of Converting Enzyme of the Renin‐Angiotensin System in Kidneys and Hindlegs of Dogs , 1972, Circulation research.

[44]  J. Ménard,et al.  Measurement of renin activity, concentration and substrate in rat plasma by radioimmunoassay of angiotensin I. , 1972, Endocrinology.

[45]  J. Vane.  Sites of Conversion of Angiotensin I , 1972 .

[46]  D W Cushman,et al.  Spectrophotometric assay and properties of the angiotensin-converting enzyme of rabbit lung. , 1971, Biochemical pharmacology.